A traditional Chinese medicine versus Western combination therapy in the treatment of rheumatoid arthritis: two-stage study protocol for a randomized controlled trial
Open Access
- 4 June 2011
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 12 (1) , 137
Abstract
Background: The common randomized controlled trial design has distinct limitations when applied to Chinese medicine, because Chinese medicine identifies and treats 'Chinese medicine patterns' rather than diagnosed diseases. Chinese medicine patterns are a group of associated symptoms, tongue appearances and pulse characteristics. These limitations could be overcome by developing new strategies to evaluate the effect of Chinese medicine. The idea behind pattern-based efficacy evaluations may optimize clinical trial design by identifying the responsiveness-related Chinese medicine patterns. Methods/Design: This is a two-stage multi-center trial of Chinese herbal medicine for the management of rheumatoid arthritis. The stage one trial is an open-label trial and aims to explore what groups of Chinese medicine information (such as symptoms) correlates with better efficacy, and the stage two trial is a randomized, controlled, double-blind, double-dummy clinical trial that incorporates the efficacy-related information identified in the stage-one trial into the inclusion criteria. Discussion: The indication of a Chinese herbal formula is a specific Chinese medicine pattern and not a single disease and stratifying a disease into several patterns with a group of symptoms is a feasible procedure in clinical trials. This study is the first to investigate whether this approach in the design of Chinese herbal medicine trials can improve responses. Trial registration: ChiCTR-TRC-10000989Keywords
This publication has 24 references indexed in Scilit:
- The effects of unilateral cochlear implantation on the tinnitus handicap inventory and the influence on quality of lifeThe Laryngoscope, 2011
- Immunomodulatory activity of a Chinese herbal drug Yi Shen Juan Bi in adjuvant arthritisIndian Journal of Pharmacology, 2010
- Study designs of randomized controlled trials not based on Chinese medicine theory are improperChinese Medicine, 2009
- Differential effect on symptoms treated with traditional Chinese medicine and western combination therapy in RA patientsComplementary Therapies in Medicine, 2008
- Correlations Between Symptoms as Assessed in Traditional Chinese Medicine (TCM) and ACR20 Efficacy ResponseJCR: Journal of Clinical Rheumatology, 2007
- Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDsNature Clinical Practice Rheumatology, 2007
- Establishing the efficacy of traditional Chinese medicineNature Clinical Practice Rheumatology, 2007
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- The american college of rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritisArthritis & Rheumatism, 1992
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988